Skip to main content
Equibles
MED logo

MED · Medifast Inc · Metrics

Track MED — free

Use MED with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MED.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$11.67 -0.06 (-0.51%) At close · Oct 5
Rebalance outlook locked
Market Cap
$136.07M
Shares
11.18M
Volume · Oct 5 65.78K Avg daily vol (3M) 151.08K

MED metrics

75 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$11.67
Market cap
$136.07M

Price action

20 metrics
Price change (1W)
-3.6%
Price change (30D)
-3.5%
Price change (3M)
+7.0%
Price change (6M)
+13.2%
Price change (YTD)
+9.8%
Price change (1Y)
-14.2%
Trailing year
Price change (5Y)
-94.0%
52-week high
$14.03
52-week low
$9.45
Change from 52-week high
-16.4%
Change from 52-week low
+24.1%
Annualized volatility
53.7%
Annualized volatility (3M)
77.4%
Beta
1.2
RSI (14D)
47.6
Price vs SMA 50
+0.4%
Price vs SMA 200
+4.2%
Avg volume (3M)
152,417
Relative volume
0.5
Average dollar volume
$1.75M

Company

3 metrics
Sector
Consumer Cyclical
Industry
Personal Services
Shares outstanding
11.18M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.4×
reciprocal yield 232.9%
P / book
0.7
reciprocal yield 144.3%
FCF yield
2.9%
TTM · current market cap
Buyback yield
0.0%
P / FCF
33.9
reciprocal yield 2.9%
P / operating cash flow
15.5
reciprocal yield 6.5%
Earnings yield
-18.8%

Historical valuation

8 metrics
P / E historical average (3Y)
67.1×
reciprocal yield 1.5%
P / E historical average (5Y)
47.6×
reciprocal yield 2.1%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-03

Profitability

9 metrics
Gross margin
69.2%
Operating margin
-6.2%
Trailing 12 months
Net margin
-8.1%
Gross profit (TTM)
$219.45M
Operating profit (TTM)
−$19.51M
Net income (TTM)
−$25.60M
Trailing 12 months
Diluted EPS (TTM)
$-2.32
FCF margin
1.3%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$18.10

Growth

11 metrics
Revenue growth YoY
-27.6%
Year over year
Net income growth YoY
-225.0%
Revenue (TTM)
$316.93M
Trailing 12 months
EPS growth YoY
-227.3%
Shares change YoY
+0.7%
Year over year · more shares
Revenue CAGR (3Y)
-37.7%
Revenue CAGR (5Y)
-16.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-80.9%
FCF CAGR (5Y)
-61.0%

Quality

14 metrics
Return on equity
-13.0%
Return on assets
-9.8%
Debt / equity
—
Current ratio
4.9
EBITDA (TTM)
−$5.66M
Free cash flow (TTM)
$4.01M
Quick ratio
4.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$71.91M
Total assets
$260.40M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$8.79M
Capital expenditures (TTM)
$4.78M
R&D (TTM)
—
SG&A (TTM)
$238.96M
Stock compensation (TTM)
$6.80M
R&D / revenue
—
Stock compensation / revenue
2.1%

Ownership (13F)

3 metrics
13F filers
115
13F filer change QoQ
-1
Institutional ownership
83.2%

Short interest

3 metrics
Short interest
16.7%
Latest settlement · 20.0 days to cover
Days to cover
20.0d
Short-squeeze score
78 / 100

Insider activity

2 metrics
Net insider buying (90D)
$1.20M
Insider-sentiment score
89 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 910329 CUSIP 58470H101 13F (30d) 2 filings 2 filers Visit website Investor relations